These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2195576)

  • 1. Antidepressant or antianxiety? A study of the efficacy of antidepressant medication.
    Kravitz HM; Fogg L; Fawcett J; Edwards J
    Psychiatry Res; 1990 May; 32(2):141-9. PubMed ID: 2195576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alprazolam: an antidepressant? Alprazolam, desipramine, and an alprazolam-desipramine combination in the treatment of adult depressed outpatients.
    Fawcett J; Edwards JH; Kravitz HM; Jeffriess H
    J Clin Psychopharmacol; 1987 Oct; 7(5):295-310. PubMed ID: 3316312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the efficacy and safety of alprazolam and desipramine in depressed outpatients.
    Remick RA; Keller FD; Buchanan RA; Gibson RE; Fleming JA
    Can J Psychiatry; 1988 Oct; 33(7):590-4. PubMed ID: 3058290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenging the amphetamine challenge test: report of an antidepressant treatment study.
    Kravitz HM; Edwards JH; Fawcett J; Fogg L
    J Affect Disord; 1990 Oct; 20(2):121-8. PubMed ID: 2148326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the safety and efficacy of alprazolam and desipramine in moderately severe depression.
    Remick RA; Fleming JA; Buchanan RA; Keller FD; Hamilton P; Loomer F; Miles JE
    Can J Psychiatry; 1985 Dec; 30(8):597-601. PubMed ID: 4084899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary depression in panic disorder: an indicator of severity with a weak effect on outcome in alprazolam and imipramine treatment.
    Rosenberg R; Bech P; Mellergård M; Ottosson JO
    Acta Psychiatr Scand Suppl; 1991; 365():39-45. PubMed ID: 1862733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid relief of anxiety in cancer patients with both alprazolam and placebo.
    Wald TG; Kathol RG; Noyes R; Carroll BT; Clamon GH
    Psychosomatics; 1993; 34(4):324-32. PubMed ID: 8351307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Alprazolam in the treatment of anxiety disorders and mixed anxiety and depressive disorders. Results of multicenter clinical trial].
    Kiejna A; Małyszczak K; Rzewuska M; Sobucka K; Florkowski A; Rajewski A; Rajewska J; Wojtanowska M; Dabkowski M; Brzeziński R; Rybakowski J; Sep-Kowalikowa B; Gałuszko P; Nowicki Z
    Psychiatr Pol; 1996; 30(6):973-92. PubMed ID: 9132771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam.
    Rickels K; Pollack MH; Feltner DE; Lydiard RB; Zimbroff DL; Bielski RJ; Tobias K; Brock JD; Zornberg GL; Pande AC
    Arch Gen Psychiatry; 2005 Sep; 62(9):1022-30. PubMed ID: 16143734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. III. Discontinuation effects.
    Pecknold JC; Swinson RP; Kuch K; Lewis CP
    Arch Gen Psychiatry; 1988 May; 45(5):429-36. PubMed ID: 3282479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the safety and efficacy of alprazolam versus other agents in the treatment of anxiety, panic, and depression: a review of the literature.
    Jonas JM; Cohon MS
    J Clin Psychiatry; 1993 Oct; 54 Suppl():25-45; discussion 46-8. PubMed ID: 8262888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lactate vulnerability after alprazolam versus placebo treatment of panic disorder.
    Cowley DS; Dager SR; Roy-Byrne PP; Avery DH; Dunner DL
    Biol Psychiatry; 1991 Jul; 30(1):49-56. PubMed ID: 1892962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coadministration of a beta-adrenergic antagonist and a tricyclic antidepressant: a pilot study.
    Tang SW; Remington G; Persad E; Rosenblat R
    Psychiatry Res; 1990 Aug; 33(2):101-6. PubMed ID: 2243886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Hamilton Anxiety Scale: reliability, validity and sensitivity to change in anxiety and depressive disorders.
    Maier W; Buller R; Philipp M; Heuser I
    J Affect Disord; 1988; 14(1):61-8. PubMed ID: 2963053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluoxetine and desipramine in major depressive disorder.
    Bowden CL; Schatzberg AF; Rosenbaum A; Contreras SA; Samson JA; Dessain E; Sayler M
    J Clin Psychopharmacol; 1993 Oct; 13(5):305-11. PubMed ID: 8227488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of alprazolam and imipramine for treatment of outpatient depression.
    Overall JE; Biggs J; Jacobs M; Holden K
    J Clin Psychiatry; 1987 Jan; 48(1):15-9. PubMed ID: 3542981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressants in concomitant chronic back pain and depression: doxepin and desipramine compared.
    Ward N; Bokan JA; Phillips M; Benedetti C; Butler S; Spengler D
    J Clin Psychiatry; 1984 Mar; 45(3 Pt 2):54-9. PubMed ID: 6321455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alprazolam: a review of its pharmacodynamic properties and efficacy in the treatment of anxiety and depression.
    Dawson GW; Jue SG; Brogden RN
    Drugs; 1984 Feb; 27(2):132-47. PubMed ID: 6141930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alprazolam versus buspirone in the treatment of outpatients with generalized anxiety disorder.
    Enkelmann R
    Psychopharmacology (Berl); 1991; 105(3):428-32. PubMed ID: 1798836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secondary depression in panic disorder and agoraphobia. I. Frequency, severity, and response to treatment.
    Lesser IM; Rubin RT; Pecknold JC; Rifkin A; Swinson RP; Lydiard RB; Burrows GD; Noyes R; DuPont RL
    Arch Gen Psychiatry; 1988 May; 45(5):437-43. PubMed ID: 3282480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.